SCHEMBL12420396

SCHEMBL12420396

CCc1ccc(-c2cn(-c3ccccc3F)nn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.50
BCHE P06276 1/20 0.48
S1PR1 P21453 2/20 0.44
GRM1 Q13255 3/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MAPT P10636 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
HSP90AA1 P07900 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
GRM5 P41594 2/20 0.40
ABCG2 Q9UNQ0 2/20 0.40
MIF P14174 1/20 0.40
ABCB1 P08183 1/20 0.40
FLT3 P36888 1/20 0.40
GSK3B P49841 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12420291 0.80 S1PR1 (0.59) S1PR1NPC1RAB9AMAPTLMNA
SCHEMBL1430355 0.78 STIM1 (0.48) S1PR1NPC1RAB9A
SCHEMBL28414389 0.78 BCHE (0.48) NOTUMBCHEGRM1CA12CA1
SCHEMBL12420394 0.77 PTGS2 (0.63) S1PR1CA12CA1CA2CA9
SCHEMBL14302898 0.76 NOTUM (0.71) NOTUMHSP90AA1CA2CA9GSK3B
SCHEMBL12420391 0.76 STS (0.59) NOTUMS1PR1CA12CA1CA2
SCHEMBL29727009 0.76 OGT (0.67) NOTUMGRM1MAPTGRM5ABCG2
SCHEMBL23405500 0.75 SNCA (0.61) NOTUMBCHEGRM1RAB9AMAPT
SCHEMBL12420293 0.73 HSD17B1 (0.56) S1PR1NPC1RAB9AMAPTCA12
SCHEMBL18031098 0.71 S1PR1 (0.60) S1PR1MAPTHSP90AA1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130096165-A1 COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS IRM LLC (BM) 2013-04-18 US disclosed
US-8362050-B2 Compounds and methods for modulating G protein-coupled receptors IRM LLC (BM) 2013-01-29 US disclosed
US-20110172278-A1 COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS IRM LLC (BM) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096165-A1 COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS GRK2, GRK3, GPR3 NOTUM 4097/4885BCHE 3120/4885S1PR1 512/4885
US-20110172278-A1 COMPOUNDS AND METHODS FOR MODULATING G PROTEIN-COUPLED RECEPTORS GRK2, GRK3, GPR3 NOTUM 4097/4885BCHE 3120/4885S1PR1 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.